Citadel Advisors’s Neovasc Inc. NVCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,355
Closed -$74K 15028
2021
Q4
$74K Buy
+6,355
New +$108K ﹤0.01% 13001
2021
Q3
Sell
-4,737
Closed -$109K 14991
2021
Q2
$109K Buy
4,737
+1,785
+60% +$40.7K ﹤0.01% 12848
2021
Q1
$80K Buy
2,952
+1,256
+74% +$42.7K ﹤0.01% 12633
2020
Q4
$40K Buy
+1,696
New +$54.5K ﹤0.01% 10654
2020
Q2
Sell
-1,420
Closed -$52K 10726
2020
Q1
$52K Buy
+1,420
New +$94.4K ﹤0.01% 9018
2019
Q3
Sell
-295
Closed -$36K 9936
2019
Q2
$36K Buy
+295
New +$36.7K ﹤0.01% 8830
2019
Q1
Sell
-517
Closed -$78K 10073
2018
Q4
$78K Buy
+517
New +$200K ﹤0.01% 8358
2018
Q3
Sell
-12
Closed -$13K 9855
2018
Q2
$13K Buy
+12
New +$12.4K ﹤0.01% 8710
2017
Q3
Sell
-1
Closed -$46K 8211
2017
Q2
$46K Hold
1
﹤0.01% 7115
2017
Q1
$20K Buy
+1
New +$37.9K ﹤0.01% 7247
2016
Q4
Hold
0
-$5K 8029
2016
Q3
Hold
0
7158

Other funds holding NVCN

Citadel Advisors's NVCN Position: Q1 2022 in Review

Citadel Advisors sold out of Neovasc Inc. (NVCN) in Q1 2022, closing a stake of 6,355 shares — an estimated $74K sold.

Citadel Advisors first reported a position in NVCN in Q1 2017 and held it in 10 quarters. The position peaked at $109K in Q2 2021. 21 funds tracked by Wall St. Rank hold NVCN as of Q1 2022.

  • Citadel Advisors reported no remaining Neovasc Inc. position as of Q1 2022 after selling out during the quarter.
  • Citadel Advisors sold 6,355 Neovasc Inc. shares in Q1 2022, an estimated $74K.
  • Citadel Advisors first reported a position in Neovasc Inc. in Q1 2017 and held it in 10 quarters.
  • Citadel Advisors's Neovasc Inc. position peaked at $109K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Neovasc Inc. as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.